“…Overall, all six WHO regions were represented, with AFR (Algeria, Ghana, Nigeria) having four studies 39 , 57 – 59 , AMR having eleven studies 40 , 42 , 45 , 47 , 54 , 55 , 60 – 64 , EMR (Iraq, Pakistan, Saudi Arabia) having eight studies 65 – 72 , EUR (all WHO European member countries) having seventeen studies 41 , 44 , 48 , 51 , 52 , 56 , 73 – 83 , SEAR (Indonesia, Bangladesh, Japan) three studies 84 – 86 , and the WPR (China, Malaysia, Australia) having twelve studies 49 , 50 , 53 , 87 – 95 . The acceptance rate among PLHIV was reported by fourteen studies 41 , 47 , 49 , 50 , 52 – 54 , 63 , 74 , 78 , 79 , 87 , 91 , 96 , the rate of intention to be vaccinated was reported by nine 50 , 52 , 63 , 74 , 78 , 79 , 87 , 91 , 96 , while uptake rate was reported by eight studies 41 , 47 , 49 , 50 , 52 – 54 , 96 . Among the LGBTQI+ community, the acceptance rate was reported by twenty-one studies 42 , 45 , …”